Tvardi Therapeutics, Inc. Cash Flow Quality Index

Latest as of December 2020: -0.65x

Tvardi Therapeutics, Inc. cash flow quality index. Tvardi Therapeutics, Inc. (TVRD) has a Cash Flow Quality Index of -0.65x as of December 2020. Operating cash flow of $-5.49 Million is below net income of $8.41 Million, suggesting accrual-heavy earnings not yet converted to cash. See Tvardi Therapeutics, Inc. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.65x
Operating CF / Net Income

Operating Cash Flow

$-5.49 Million
USD

Net Income

$8.41 Million
USD

Data as of

Dec 2020
Most recent filing

Cash Flow Quality Index of Tvardi Therapeutics, Inc. (2020–2020)

Cash flow quality index of Tvardi Therapeutics, Inc. from 2020 to 2020. Historical Cash Flow Quality Index for Tvardi Therapeutics, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore TVRD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Tvardi Therapeutics, Inc. Cash Flow Quality Index by Year (2020–2020)

Tvardi Therapeutics, Inc. cash flow quality index by year from 2020 to 2020. Year-by-year earnings quality comparison for Tvardi Therapeutics, Inc.. For the full cash flow conversion analysis, see how efficiently does Tvardi Therapeutics, Inc. generate cash.

Year Quality Index Operating CF (USD) Net Income YoY Change
2020 -0.65x $-5.49 Million $8.41 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.